🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07588035
Starting soon Not applicable

Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline

NCT07588035 · tracked via the Priya Life Science China tracker
Sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Started
2026-04-20
Last updated
2026-05-14

Condition(s) studied

InsomniaSleep

Investigational drug(s) / intervention(s)

Artificial Intelligence (AI)-assisted sleep interventionUsual Care

Artificial Intelligence (AI)-assisted sleep intervention: Six weeks of AI-assisted sleep intervention

Usual Care: The standard care participants receive from the healthcare system and/or their daily routines to address insomnia symptoms

Study summary

To assess the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.

Eligibility

Sex
ALL
Min age
60 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * older adults aged ≥ 60 years * Subjective cognitive decline questionnaire 9 (SCD-Q9) ≥ 5 * Montreal Cognitive Assessment (MoCA) ≥ 26. If the number of years of education is less than 12, one point will be added to the total score; * with insomnia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and Insomnia Severity Index (ISI) ≥ 8 * reachable by phone Exclusion Criteria: * having a previously diagnosed primary sleep disorder, such as sleep apnoea * suffering from a severe chronic illness that could contribute to sleep problems (e.g., emphysema) * currently undergoing medical, psychological, or psychiatric treatment for sleep disturbances or depression * having significant visual or hearing impairments.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Qingyuan Second People's Hospital Qingyuan Guangdong

More The Hong Kong Polytechnic University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07588035 on ClinicalTrials.gov ↗ ← All trials in China